35 percent of patients with breast cancer worried about genetic risks to themselves, family members
the ONA take:
According to a new study conducted at the University of Michigan Comprehensive Cancer Center in Ann Arbor, Michigan, researchers have found that a third of women diagnosed with breast cancer are concerned about the genetic risk of a family member developing cancer or developing other cancers themselves.
For the study, researchers surveyed 1,536 women who had been treated for breast cancer that were included in the Surveillance, Epidemiology and End Results (SEER) databases.
Results showed that 35% of women with breast cancer expressed a strong desire for genetic testing, while 43% did not have a discussion about genetic testing with a health care professional.
The study also found that racial minority participants were less likely than white patients to discuss genetic testing with a health care professional despite a strong desire to do so.
Researchers found that many patients, particularly Latinas who spoke only Spanish, were concerned that their loved ones might get breast cancer in the future due to inherited risk.
Study results were published in the Journal of Clinical Oncology.
A third of women diagnosed with breast cancer are concerned about the genetic risk of a family member developing cancer.
- Osteoporosis Medication Improves Bone Health in ADT-Treated Prostate Cancer
- Inotuzumab Ozogamicin Granted FDA Approval for Acute Lymphoblastic Leukemia
- Cabazitaxel in Prostate Cancer: Reduced Dose Noninferior to Standard Dose
- Risk of Some Cancers Higher in Women With a History of Periodontal Disease
- Breast Conservation Improves Survival vs Mastectomy in Breast Cancer
- To Better Serve Patients With Cancer, Navigators Need Better Systems
- Physical Activity Improves Cognitive Function for Breast Cancer Survivors
- Risk of Lung Cancer Increases With Diets Higher in Saturated Fats
- Mechanisms Identified for Curcumin Resensitization of Cancer Cells
- Value of Type and Crossmatch Prior to Daratumumab Administration
- Affect of Daratumumab on Laboratory Blood Test Results
- Geriatric Consults Rare in Kidney Cancer Care
- Worse Survival Seen for Alternative Versus Usual Cancer Therapy
- Anorexia-Cachexia in Non-Small Cell Lung Cancer Improved With Anamorelin
- Early Recognition of Checkpoint Inhibitor-Related Pneumonitis Improves Outcomes
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|